SYK - MedTech stocks gain after Novo Nordisk data for weight loss therapy
2023-11-13 12:13:48 ET
More on DexCom, Novo, etc.
- Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript)
- Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise
- Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Conference (Transcript)
- Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug
- Novo Nordisk details heart benefits of weight loss drug from Phase 3 trial
For further details see:
MedTech stocks gain after Novo Nordisk data for weight loss therapy